ADVANCED MACHINE VISION CORP
S-3/A, 1998-07-10
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Previous: ADVANCED MACHINE VISION CORP, 10-K/A, 1998-07-10
Next: METAL MANAGEMENT INC, 8-K/A, 1998-07-10




- --------------------------------------------------------------------------------
      As filed with the Securities and Exchange Commission on July 10, 1998
                           Registration No. 333-53787
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                               Amendment No. 1 to
                                    FORM S-3


                             REGISTRATION STATEMENT
                        UNDER THE SECURITIES ACT OF 1933


                       ADVANCED MACHINE VISION CORPORATION
             (Exact name of registrant as specified in its charter)


        California              2067 Commerce Drive          33-0256103
(State or other jurisdiction     Medford, OR 97504        (I.R.S. Employer
    of incorporation or            541-776-7700          Identification No.)
       organization)       (Address and telephone number
                            of Registrant's principal
                               executive offices)


                                  Alan R. Steel
                               2067 Commerce Drive
                                Medford, OR 97504
                                Tel. 541-776-7700
                                Fax. 541-779-6838
            (Name, address and telephone number of agent for service)
                            ------------------------


          Approximate date of commencement of proposed sale to public:
               As soon as practicable following the effectiveness
                         of this Registration Statement.


If the only securities  being registered on this form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. |_|

If any of the  securities  being  registered on this form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. |X|

If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the  Securities  Act  registration  statement  number of the  earlier  effective
registration statement for the same offering. |_|

If this Form is a  post-effective  amendment filed pursuant to Rule 462(c) under
the Securities  Act,  please check the following box and list the Securities Act
registration  statement number of the earlier effective  registration  statement
for the same offering. |_|

If  delivery  of  the  prospectus  is  expected to be made pursuant to Rule 434,
please check the following box. |_|

The Registrant hereby amends this  Registration  Statement on such date or dates
as may be necessary to delay its effective date until the Registrant  shall file
a further amendment which specifically  states that this Registration  Statement
shall  thereafter  become  effective  in  accordance  with  Section  8(a) of the
Securities  Act of  1933  or  until  the  Registration  Statement  shall  become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.

- --------------------------------------------------------------------------------
================================================================================
<PAGE>

                   SUBJECT TO COMPLETION, DATED JULY 10, 1998

Information   contained  herein  is  subject  to  completion  or  amendment.   A
registration  statement  relating  to these  securities  has been filed with the
Securities  and Exchange  Commission.  These  securities may not be sold nor may
offers to buy be accepted prior to the time the registration  statement  becomes
effective.  This  prospectus  shall  not  constitute  an  offer  to  sell or the
solicitation of an offer to buy nor shall there be any sale of these  securities
in any state in which such offer,  solicitation  or sale would be unlawful prior
to registration or qualification under the securities laws of any such state.

PROSPECTUS

                       ADVANCED MACHINE VISION CORPORATION
                     652,500 Shares of Class A Common Stock

This  Prospectus  relates to the offer by certain  securityholders  named herein
(the "Selling  Securityholders")  for sale to the public from time to time of up
to (i) 232,500 shares of restricted Class A Common Stock (the "Common Stock") of
Advanced Machine Vision Corporation  ("AMV" or the "Company"),  and (ii) 420,000
shares of Common  Stock  issuable  upon the  exercise of certain  stock  options
granted to  directors  of, and  consultants  to, the Company.  Unless  otherwise
indicated  herein,  references  herein to the "Company"  means Advanced  Machine
Vision Corporation and its subsidiaries.

With respect to 200,000 shares of restricted  Common Stock, the shares cannot be
traded or  transferred  unless  (i) the  employee  remains  in the employ of the
Company until January 10, 2000, and (ii) a payment of $1.80 per share is made by
the employee to AMV. If any of these  conditions are not met, the related shares
of stock will be forfeited  and returned to the Company.  With respect to 32,500
shares of restricted stock, the shares cannot be traded until January 1, 1999.

The  420,000  shares of Common  Stock are  issuable  upon the  exercise of stock
options at prices  ranging from $1.56 to $2.03 per share.  Such  options  expire
between 2002 and 2003.

The Common Stock is traded on the Nasdaq  Stock Market under the symbol  "AMVC."
As of July 7, 1998,  the last sale price for the Common Stock as reported on the
Nasdaq Stock Market was $1.91.

This  offering  is not being  underwritten.  The  Selling  Securityholders  have
advised the Company that they may sell,  directly or through  brokers,  all or a
portion  of the  shares  of  Common  Stock  owned by each of them in  negotiated
transactions  or in  transactions  on the Nasdaq  Stock  Market or  otherwise at
prices and terms  prevailing at the time of sale. It is  anticipated  that usual
and customary  brokerage  fees will be paid by the Selling  Securityholders.  In
connection with such sales, the Selling  Securityholders  and any  participating
broker or dealer may be deemed to be  "underwriters"  of the  Shares  within the
meaning of the Securities Act of 1933, as amended (the "Securities Act").

The Company has informed the Selling  Securityholders that the anti-manipulation
provisions  of Rules 10b-6 and 10b-7 under the  Securities  Exchange Act of 1934
(the  "Exchange  Act") may apply to their sales of the Shares.  The Company also
has advised the Selling Securityholders of the requirements for delivery of this
Prospectus in connection with any sale of the Shares.

See "Risk  Factors"  beginning on page 5 of this  Prospectus for a discussion of
certain  material  risks  associated  with an investment  in the Shares  offered
hereby.

  THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
  EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES
     AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON
     THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE
                         CONTRARY IS A CRIMINAL OFFENSE.

              The date of this Prospectus is ________________, 1998


                              AVAILABLE INFORMATION

The  Company is  subject to the  informational  requirements  of the  Securities
Exchange  Act of 1934,  as amended,  (the  "Exchange  Act") and,  in  accordance
therewith, files reports, proxy or information statements, and other information
with the Securities and Exchange  Commission (the  "Commission").  Such reports,
proxy  statements,  and other  information  can be  inspected  and copied at the
public reference facilities maintained by the Commission at Judiciary Plaza, 450
Fifth Street NW,  Washington,  DC 20549,  as well as at the  following  regional
offices:  7 World Trade Center,  New York,  NY 10048,  and  Northwestern  Atrium
Center, 500 W Madison Street #1400,  Chicago, IL 60661. Copies of such materials
also can be obtained  from the Public  Reference  Section of the  Commission  at
Judiciary Plaza, 450 Fifth Street NW, Washington, DC 20549, at prescribed rates.
The  Securities  are traded on the Nasdaq Market  (small-cap)  and the Company's
reports,  proxy or  information  statements,  and other  information  filed with
Nasdaq may be inspected at Nasdaq's offices at 1735 K Street NW, Washington,  DC
20006.  The  Commission  maintains a World Wide Web site that contains  reports,
proxy and information  statements and other  information  regarding  registrants
that file  electronically  with the Commission.  The address of the Commission's
World Wide Web site is http:/www.sec.gov.

Additional information regarding the Company and the Common Stock offered hereby
is contained in the Registration  Statement on Form S-3 of which this Prospectus
is a part  (including all exhibits and  amendments  thereto,  the  "Registration
Statement"),  filed with the  Commission  under the  Securities  Act of 1933, as
amended  (the  "Securities  Act").  For further  information  pertaining  to the
Company and the Common Stock,  reference is made to the  Registration  Statement
and the exhibits thereto,  which may be inspected and copied at the Commission's
public reference facilities at Judiciary Plaza, 450 Fifth Street NW, Washington,
DC 20549.


                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

The  following  documents  which  have  been  previously  filed  by the  Company
(Commission  File No.  0-20097) with the  Commission  under the Exchange Act are
incorporated in this Prospectus by reference: (a) the Company's Annual Report on
Form 10-K/A for the year ended  December 31, 1997;  (b) the Company's  Quarterly
Report on Form 10-Q for the quarter ended March 31, 1998;  and (c) the Company's
current reports on Form 8-K filed on February 27, 1998 (date of report:  January
1, 1998) and June 15, 1998 (date of report: June 5, 1998).

All documents  filed by the Company  pursuant to Section  13(a),  13(c),  14 and
15(d) of the Exchange Act subsequent to the date of this Prospectus and prior to
the termination of this offering shall be deemed to be incorporated by reference
into this Prospectus and to be a part of this Prospectus from the date of filing
of such documents.  Any statement contained in a document incorporated or deemed
to be  incorporated  by  reference  herein  shall be  deemed to be  modified  or
superseded  for  purposes  of this  Prospectus  to the extent  that a  statement
contained herein (or in any other  subsequently filed document which also is, or
is deemed to be,  incorporated by reference  herein) modifies or supersedes such
statement.  Any such  statement so modified or  superseded  shall not be deemed,
except as so modified or superseded, to constitute a part of this Prospectus.

On request,  the Company will provide,  without  charge,  to each person to whom
this   Prospectus  is  delivered   a  copy  of  any  or  all  of  the  documents
incorporated  by reference  (other than exhibits to such  documents that are not
specifically  incorporated  by reference in such  documents).  Requests for such
copies should be directed to Advanced Machine Vision Corporation,  2067 Commerce
Drive,  Medford,  OR  97504,  Attention:  Alan  R.  Steel,  or by  telephone  at
541-776-7700.

<PAGE>

                               PROSPECTUS SUMMARY

     The  following  summary is qualified  in its entirety by the more  detailed
information  and the  financial  statements  and notes thereto  incorporated  by
reference  herein.  An  investment in the  Securities  offered  hereby  involves
certain  material  risks.  Prospective  investors should carefully  consider the
factors  discussed  under  "Risk  Factors."  Unless  otherwise  indicated,   the
information  contained  in  the Prospectus assumes that outstanding warrants and
outstanding options under the  Company's  stock  option plans,  except for those
listed as being sold under Selling Securityholders, are not exercised.


                                  The Offering


Class A Common Stock offered hereby.......    652,500 shares

Class A Common Stock outstanding
  before offering......................... 10,641,718 shares (3)

Class A Common Stock outstanding
  after offerings and exercise of
  underlying securities (1)............... 11,061,718 shares (3)

Class B Common Stock outstanding
  before and after offering(2)............     76,835 shares

Use of  Proceeds.......................... All of the proceeds from the sale of
                                           the Securities offered hereby will be
                                           received by the Selling Security-
                                           holders. The Company will not receive
                                           any of the proceeds from this
                                           offering but will bear estimated
                                           expenses of approximately $25,000.

Risk Factors.............................. The securities offered hereby involve
                                           a high degree of risk. See "Risk
                                           Factors."

NASDAQ Symbol............................. Class A Common Stock - AMVC

(1) Assumes that options to purchase 420,000 shares are exercised. See "Risk
    Factors - Need for Additional Financing."

(2) The Class A Common Stock and the Class B Common Stock are substantially
    identical except that the Class B Common Stock has limited transferability.

(3) Based on 10,641,718 shares of Class A Common Stock outstanding as of 
    June 30, 1998.

<PAGE>


                                  RISK FACTORS


Cautionary Statements and Risk Factors

The Company and its  representatives  may from time to time make written or oral
forward-looking  statements with respect to long-term objectives or expectations
of the Company, including statements contained in the Company's filings with the
Securities and Exchange Commission and in its reports to stockholders.

The words or phrases "will  likely," "are  expected to," "is  anticipated,"  "is
predicted,"  "forecast," "estimate," "project," "plans to continue," "believes,"
or similar expressions identify "forward-looking  statements" within the meaning
of the Private  Securities  Litigation Reform Act of 1995. Such  forward-looking
statements  are  subject to certain  risks and  uncertainties  that could  cause
actual results to differ materially from historical earnings and those presently
anticipated  or projected.  The Company  wishes to caution  readers not to place
undue reliance on any such  forward-looking  statements,  which speak only as of
the date made.  In connection  with the "Safe Harbor"  provisions on the Private
Securities  Litigation  Reform Act of 1995,  the  Company is hereby  identifying
important  factors that could affect the  Company's  financial  performance  and
could cause the Company's actual results for future periods to differ materially
from any opinions or statements  expressed with respect to future periods in any
current statements.

The Company cautions that the following list of important factors may not be all
inclusive,  and it specifically declines to undertake any obligation to publicly
revise any  forward-looking  statements that have been made to reflect events or
circumstances  after the date of such statements or to reflect the occurrence of
anticipated or unanticipated events. Among the factors that could have an impact
on the Company's  ability to achieve its operating results and growth plan goals
and/or affect the market price of the Company's stock are:

   * The Company's history of losses and negative cash flow.
   * The uncertain ability to manage growth and integrate acquired businesses.
   * The uncertain ability to develop technologically competitive products and
     adapt to rapid technological change.
   * The uncertainty of market acceptance of the Company's new products.
   * AMV's dependence on certain markets and the need to expand into new
     markets.
   * The lengthy sales cycle for the Company's products.
   * The Company's highly competitive marketplace.
   * The dependence on sole or a limited number of suppliers.
   * The risks associated with dependence upon significant customers and
     reliance on certain distributors.
   * The risks associated with international sales.
   * Fluctuations in quarterly operating results and seasonality in certain of
     the Company's markets.
   * Risks associated with acquisitions and other relationships. 
   * Dependence upon key personnel.
   * The Company's ability to protect its intellectual property.
   * The possibility of product liability or other legal claims.
   * Exposure to possible warranty and litigation claims. 
   * The possible need for additional financing.
   * The anti-takeover effects of the 1998 Shareholder Rights Plan.
   * The inability of the Company or its suppliers or customers to remedy
     potential problems with information systems related to the arrival of the
     year 2000.

These risk factors are discussed in further detail below.

History of Losses;  Negative Cash Flow:  Prior to 1995 and in 1996,  the Company
experienced losses and negative operating cash flow. The Company believes it may
operate at a negative cash flow for certain periods in the future due to (i) the
need to fund  certain  development  projects,  (ii) cash  required  to enter new
market areas,  (iii) irregular  bookings by customers due to the relatively high
per-unit  cost  of the  Company's  products  which  may  cause  fluctuations  in
quarterly or yearly  revenues,  (iv) cash  required  for the  repayment of debt,
especially $3.25 million due in July 1999, and (v) possible cash needed to fully
integrate the  operations of the  Company's  SRC VISION,  Inc. and Ventek,  Inc.
subsidiaries.  If the  Company  is unable  to  consistently  generate  sustained
positive  cash flow from  operations,  the  Company  must rely on debt or equity
financing.

Although the Company  achieved  profitability  in 1995 and 1997, there can be no
assurance as to the  Company's  profitability  on a quarterly or annual basis in
the future. Furthermore,  the non-recurring expenses in early 1996 resulted in a
significant loss for the 1996 fiscal year.

Uncertain Ability to Manage Growth and Integrate Acquired Businesses: As part of
its business strategy,  the Company intends to pursue rapid growth. In March and
July 1996,  the Company  acquired  Pulsarr and Ventek which had sales in 1995 of
approximately $11.4 million and $4.4 million, respectively, and would have added
approximately  80% to the Company's 1995 sales on a proforma basis.  Pulsarr was
subsequently  sold in May 1997  pursuant  to an  unsolicited  offer,  which sale
provided the Company with cash for financial  flexibility and eliminated certain
potential  liabilities  related to non-vision  products sold by Pulsarr in prior
years. A growth  strategy  involving the  integration  of new entities,  such as
Ventek, will require the establishment of sales representatives and distribution
relationships,  expanded  customer  service  and  support,  increased  personnel
throughout the Company and the continued  implementation  and improvement of the
Company's operational, financial and management information systems. There is no
assurance  that the Company  will be able to attract  qualified  personnel or to
accomplish other measures necessary for its successful  integration of Ventek or
other  acquired  entities  or for  internal  growth,  or that  the  Company  can
successfully  manage expanded  operations.  As the Company expands,  it may from
time to time experience  constraints  that will adversely  affect its ability to
satisfy  customer  demand  in  a  timely  fashion.   Failure  to  manage  growth
effectively could adversely affect the Company's financial condition and results
of operations.

Uncertain Ability to Develop  Technologically  Competitive Products and Adapt to
Rapid  Technological  Change:  The  markets  for the  Company's  machine  vision
products are  characterized by rapidly changing  technology,  evolving  industry
standards and frequent new product introductions and enhancements.  For example,
the Company believes that the 1995  introduction by Key Technology,  Inc. of its
new line of vision sorting  equipment  adversely  affected bookings in late 1995
and 1996.  Sales of the  Company's  products  depend  in part on the  continuing
development and deployment of new technology and services and applications.  The
Company's  success  will  depend to a  significant  extent  upon its  ability to
enhance  its  existing  products  and  develop  new  products  that gain  market
acceptance.  There can be no assurance  that the Company will be  successful  in
selecting,  developing and  manufacturing new products or enhancing its existing
products on a timely or  cost-effective  basis or that products or  technologies
developed by others will not render the  Company's  products  noncompetitive  or
obsolete.  Moreover,  the Company may encounter technical problems in connection
with its product  development  that could result in the delayed  introduction of
new products or product enhancements.

Uncertainty of Market Acceptance of New Products: The Company's future operating
results will depend upon its ability to successfully  introduce and market, on a
timely and  cost-effective  basis,  new  products and  enhancements  to existing
products.  There can be no  assurance  that new  products  or  enhancements,  if
developed  and  manufactured,  will achieve  market  acceptance.  The Company is
currently in the initial  prototype  stage of  development  on a new  high-speed
software and digital  signal  processing  technology  designed to  significantly
improve  system  performance.  There can be no assurance  that a market for this
system will  develop  (i.e.,  that a need for the system  will  exist,  that the
system will be favored over other products on the market,  etc.) or, if a market
does develop,  that the Company will be able,  financially or operationally,  to
market and support the system successfully.

Dependence on Certain Markets and Expansion Into New Markets: The future success
and growth of the Company is  dependent  upon  continuing  sales in domestic and
international food processing markets as well as successful penetration of other
existing  and  potential  markets.  A  substantial   portion  of  the  Company's
historical sales has been in the potato and other vegetable  processing markets.
Reductions in capital equipment expenditures by such processors due to commodity
surpluses,  product price fluctuations,  changing consumer  preferences or other
factors could have an adverse effect on the Company's results of operations. The
Company  also  intends  to expand the  marketing  of its  processing  systems in
additional  food  markets such as meat and granular  food  products,  as well as
non-food markets such as plastics,  wood products and tobacco, and to expand its
sales  activities in foreign markets.  In the case of Ventek,  the wood products
market  served is narrow and  cyclical,  and  saturation  of that market and the
potential  inability to identify and develop new markets could adversely  affect
Ventek's  growth  rate.  The Company may not be able to  successfully  penetrate
additional food and non-food markets or expand further in foreign markets.

Lengthy Sales Cycle:  The sales cycle in the marketing and sale of the Company's
machine vision systems,  especially in new markets or in a new  application,  is
lengthy and can be as long as three years. Even in existing markets,  due to the
$150,000  to  $600,000  price  range for each  system and  possibly  significant
ancillary costs required for a customer to install the system, the purchase of a
machine  vision system can  constitute a substantial  capital  investment  for a
customer  (which  may need more than one  machine  for its  particular  proposed
application)  requiring lengthy consideration and evaluation.  In particular,  a
potential customer must develop a high degree of assurance that the product will
meet its needs,  successfully  interface with the customer's own  manufacturing,
production or processing system,  and have minimal warranty,  safety and service
problems.  Accordingly,  the time lag from  initiation  of marketing  efforts to
final sales can be lengthy.

Highly  Competitive  Markets:  The markets for the Company's products are highly
competitive.  A major competitor of the Company  introduced  several years ago a
new flat-belt  optical sorter product which has increased the  competition  that
the Company faces. In the case of Ventek, the wood industry continues to develop
alternative  products to plywood  (e.g.,  oriented  strand  board)  which do not
require vision systems for quality control.  Some of the Company's  competitors,
including Pulsarr,  which was sold in May 1997 to a company significantly larger
than AMV, may have  substantially  greater financial,  technical,  marketing and
other resources than the Company. Important competitive factors in the Company's
markets include price, performance,  reliability,  customer support and service.
Although  the Company  believes  that it  currently  competes  effectively  with
respect to these  factors,  the  Company  may not be able to continue to compete
effectively in the future.

Dependence  Upon Sole or a Limited  Number of Suppliers:  Certain key components
and  subassemblies  used in the Company's  products are currently  obtained from
sole sources or a limited group of suppliers,  and the Company does not have any
long-term  supply  agreements  to  ensure  an  uninterrupted   supply  of  these
components.  Although the Company seeks to reduce  dependence on sole or limited
source  suppliers,  the inability to obtain  sufficient  sole or limited  source
components as required,  or to develop  alternative  sources if and as required,
could result in delays or reductions in product shipments which could materially
and adversely  affect the Company's  results of operations  and damage  customer
relationships.  The purchase of certain of the components  used in the Company's
products  require  an 8 to 12 week  lead  time for  delivery.  An  unanticipated
shortage  of such  components  could  delay  the  Company's  ability  to  timely
manufacture units, damage customer relations, and have a material adverse effect
on the Company. In addition,  a significant increase in the price of one or more
of these  components  or  subassemblies  could  adversely  affect the  Company's
results of operations.

Dependence Upon Significant Customers and Distribution Channel: The Company sold
equipment to an unaffiliated  customer  totaling 14% of sales in 1997 and to two
unaffiliated  customers  totaling 13% and 12% of sales in 1996. Sales to another
two unaffiliated  customers totaled 19% and 16% of sales in 1995. Ventek's sales
have been to a relatively small number of multi-location  plywood manufacturers.
In the emerging  pulp wood  industry,  the Company  utilizes a single  exclusive
distributor for its products in North America.  In much of the United States and
in many areas in the rest of the world,  the Company  has  entered an  agreement
with FMC Corporation to be its exclusive sales representative. While the Company
strives to create long-term  relationships with its customers,  distributors and
representatives,  there can be no assurance that they will continue  ordering or
selling additional systems.  The Company may continue to be dependent on a small
number of customers, distributors and representatives,  the loss of any of which
would adversely affect the Company's business.

Risk of International  Sales: Due to its export sales, the Company is subject to
the risks of conducting business  internationally,  including unexpected changes
in regulatory requirements;  fluctuations in the value of the U. S. dollar which
could increase the sales prices in local currencies of the Company's products in
international  markets;  delays in obtaining export licenses,  tariffs and other
barriers  and  restrictions;  and the  burdens  of  complying  with a variety of
international  laws.  For  example,  the  possibility  of  sales  to  Indonesian
customers  has  been  adversely  affected  by  that  country's  recent  currency
devaluation.  In addition, the laws of certain foreign countries may not protect
the Company's  intellectual property rights to the same extent as do the laws of
the United States.

Fluctuations  in  Quarterly  Operating  Results;  Seasonality:  The  Company has
experienced  and  may in  the  future  experience  significant  fluctuations  in
revenues and  operating  results from quarter to quarter as a result of a number
of factors, many of which are outside the control of the Company.  These factors
include the timing of significant  orders and shipments,  product mix, delays in
shipment,  capital spending patterns of customers,  competition and pricing, new
product introductions by the Company or its competitors,  the timing of research
and  development  expenditures,  expansion of marketing and support  operations,
changes  in  material   costs,   production   or  quality   problems,   currency
fluctuations,  disruptions in sources of supply,  regulatory changes and general
economic conditions. These factors are difficult to forecast, and these or other
factors  could have a material  adverse  effect on the  Company's  business  and
operating results.  Moreover,  due to the relatively fixed nature of many of the
Company's costs, including personnel and facilities costs, the Company would not
be  able to  reduce  costs  in any  quarter  to  compensate  for any  unexpected
shortfall  in net  sales,  and such a  shortfall  would  have a  proportionately
greater  impact on the  Company's  results of operations  for that quarter.  For
example, a significant portion of the Company's quarterly net sales depends upon
sales of a relatively small number of high-priced systems.  Thus, changes in the
number of such  systems  shipped in any given  quarter can  produce  substantial
fluctuations  in net  sales,  gross  profits,  and net  income  from  quarter to
quarter. In addition, in the event the Company's machine vision systems' average
selling price  increases,  of which there can be no  assurance,  the addition or
cancellation  of sales may  exacerbate  quarterly  fluctuations  in revenues and
operating results.

The Company's operating results may also be affected by certain seasonal trends.
For  example,  the Company may  experience  lower sales and order  levels in the
first  quarter  when  compared  with the  preceding  fourth  quarter  due to the
seasonality  of  certain  harvested  food  items  and the  timing  of  annual or
semi-annual  customer plant shut-downs  during which systems are installed.  The
Company  expects  these  seasonal  patterns to continue,  though their impact on
revenues is expected to decline as the Company  continues to expand its presence
in non-agricultural and other markets which are less seasonal.

Risks   Associated  With   Acquisitions:   The  Company  may  pursue   strategic
acquisitions  or joint  ventures  in  addition  to the  acquisitions  of Pulsarr
(subsequently  divested in May 1997) and Ventek as part of its growth  strategy.
While the Company  presently has no  understandings,  commitments  or agreements
with respect to any further  acquisition,  the Company  anticipates  that one or
more potential  opportunities  may become available in the future.  Acquisitions
and joint  ventures  would  require  investment  of  operational  and  financial
resources and could require integration of dissimilar  operations,  assimilation
of new employees, diversion of management resources, increases in administrative
costs and additional costs associated with debt or equity  financing.  For these
reasons,  any  acquisition  or joint  venture by the Company may have an adverse
effect on the  Company's  results of  operations  or may result in  dilution  to
existing shareholders.

Dependence  Upon Key Personnel:  The Company's  success depends to a significant
extent upon the continuing contributions of its key management, technical, sales
and  marketing  and other key  personnel.  Except  for  William  J.  Young,  the
Company's  President and Chief Executive  Officer,  Alan R. Steel, the Company's
Chief  Financial  Officer,  Dr. James Ewan,  SRC's President and Chief Executive
Officer,  and the four former  stockholders of Ventek, the Company does not have
long-term  employment  agreements or other  arrangements  with such  individuals
which would  encourage  them to remain with the Company.  The  Company's  future
success also depends upon its ability to attract and retain  additional  skilled
personnel.  Competition  for such employees is intense.  The loss of any current
key  employees or the inability to attract and retain  additional  key personnel
could have a material  adverse  effect on the  Company's  business and operating
results.

Uncertain Ability to Protect Intellectual  Property:  The Company's  competitive
position may be affected by its ability to protect its  proprietary  technology.
Although  the Company has a number of United  States and foreign  patents,  such
patents may not provide meaningful  protection for its product innovations.  The
Company may experience  additional  intellectual property risks in international
markets where it lacks patent protection.

Product Liability and Other Legal Claims:  From time to time, the Company may be
involved  in  litigation  arising  out of the  normal  course  of its  business,
including product  liability,  patent and other legal claims.  While the Company
has a general  liability  insurance  policy  which  includes  product  liability
coverage up to an aggregate  amount of $10 million,  the Company may not be able
to maintain  product  liability  insurance  on  acceptable  terms in the future.
Litigation,  regardless of its outcome,  could result in substantial cost to and
diversion  of effort  by the  Company.  Any  infringement  claims or  litigation
against  the  Company  could  materially  and  adversely  affect  the  Company's
business,  operating results and financial  condition.  If a substantial product
liability or other legal claim against the Company were  sustained  that was not
covered  by  insurance,  there  could  be an  adverse  effect  on the  Company's
financial condition and marketability of the affected products.

Warranty Exposure and Performance Specifications: The Company generally provides
a  one-year  limited  warranty  on  its  products.  In  addition,   for  certain
custom-designed  systems,  the Company  contracts  to meet  certain  performance
specifications.  In the past, the Company has incurred higher warranty  expenses
related to new products than it typically incurs with established products.  The
Company may incur  substantial  warranty  expenses in the future with respect to
new  products,  as  well  as  established  products,  or  with  respect  to  its
obligations to meet performance specifications, which may have an adverse effect
on its results of  operations  and  customer  relationships.  

Possible  Need  for  Additional  Financing:  The  Company  may  seek  additional
financing;  however,  the  Company  may  not be able to  obtain  any  additional
financing on terms satisfactory to the Company,  if at all. Potential  increases
in the number of outstanding shares of the Company's Class A Common Stock due to
convertible  debt,  warrants and stock options,  a substantial  loss in 1996 and
debt incurred for the acquisition of Ventek due in 1999, may limit the Company's
ability to negotiate additional debt or equity financing.

Anti-Takeover  Effects  of  Shareholder  Rights  Plan and  Preferred  Stock:  In
February 1998, the Company  implemented a stock rights program.  Pursuant to the
program,  stockholders of record on February 27, 1998 received a dividend of one
right to purchase for $15 one one-hundredth of a share of a newly created Series
A Junior Participating Preferred Stock. The rights are attached to AMV's Class A
Common Stock and will also become  attached to shares issued in the future.  The
rights will not be traded  separately and will not become  exercisable until the
occurrence of a triggering event,  defined as an accumulation by a single person
or group of 20% or more of AMV's Class A Common Stock. The rights will expire on
February 26, 2008 and are redeemable at $.0001 per right.

After a triggering  event, the rights will detach from the Class A Common Stock.
If AMV is then merged into, or is acquired by, another corporation,  the Company
has the  opportunity  to either (i) redeem the rights or (ii)  permit the rights
holder  to  exercise  the  rights  and  receive  therefore  stock  of AMV or the
acquiring  company  equal to two times the  exercise  price of the right  (i.e.,
$30).  Under  clause (ii) above,  the rights  attached to the  acquirer's  stock
become  null and void.  The effect of the rights  program is to make a potential
acquisition of the Company more expensive for the acquirer if, in the opinion of
AMV's Board of Directors, the offer is inadequate.

While the  Company is not aware of any  current  intent to acquire a  sufficient
number of shares of the Company's  Common Stock to trigger  distribution  of the
Rights,  existence of the Rights could discourage offers for the Company's stock
that may exceed the  current  market  price of the stock,  but that the Board of
Directors  deems  inadequate.  As of June 30, 1998, the Company did not have any
Preferred  Stock  outstanding.  The issuance of Preferred  Stock could adversely
effect  the  voting  power  of the  holders  of  Common  Stock  and,  under  the
circumstances  listed  above,  make it more  difficult for a third party to gain
control of the Company.

Year 2000 Issues:  AMV has established a company-wide  initiative to examine the
implications  of the Year 2000 on the  Company's  computing  systems and related
technologies,  and to assess the  potential  need for  changes.  The Company has
identified areas of potential business impact, and appropriate  modifications to
its  computing   systems  are  underway.   Management   believes  this  will  be
accomplished  in a  timely  manner.  The  Company  is  also  communicating  with
suppliers and customers to coordinate Year 2000 conversion.  Management does not
currently  believe that the costs related to the Company's  compliance  with the
Year 2000 issue will have a material  adverse effect on the Company's  financial
position,  results of operations or cash flows.  However,  in the event that the
Company or any of the Company's  significant  suppliers or customers  experience
disruptions  due to the Year  2000  issue,  the  Company's  operations  could be
adversely affected.


                                 USE OF PROCEEDS

Other than the exercise price of such of the Options as may be exercised and the
purchase  price of a portion  of the  restricted  stock,  the  Company  will not
receive any of the proceeds  from the sale of the Common Stock  offered  hereby.
The  Company  will pay the costs of this  offering,  which are  estimated  to be
$25,000,  other than  brokerage  and  counsel  fees which may be  incurred  by a
Selling Securityholder.  Holders of the Options or the portion of the restricted
stock subject to payment  provisions are not obligated to exercise their Options
or purchase  the  restricted  shares,  and there can be no  assurance  that such
holders  will  choose to  exercise  or  purchase  all or any of such  Options or
shares.  The gross  proceeds to the Company in the event that all of the Options
are exercised and restricted shares are purchased would be as follows:

                           Number of
                            Warrants        Exercise Price      Proceeds to
                           or Options          per Share          Company
                           ----------       --------------      -----------

Restricted Shares:          200,000            $ 1.80         $    360,000

Options:                    300,000              1.69              507,000
                             30,000              2.00               60,000
                             75,000              1.56              117,000
                             15,000              2.03               30,450
                                                              ------------

      Total                                                   $  1,074,450
                                                              ============

The Company  intends to apply the net proceeds it receives  from exercise of the
Options or purchase of the restricted  shares,  to the extent any are exercised,
to augment its working capital and for general corporate purposes.


                             SELLING SECURITYHOLDERS

All  of  the   Securities   offered   hereby  are  being  sold  by  the  Selling
Securityholders.
<TABLE>
<CAPTION>
                                                                                                Ownership
                                        Ownership Prior to Registration                      After Offering
                               --------------------------------------------------      -----------------------------
                                                                  Type and Number
                                Type and Number                    of Securities       Type and Number
 Beneficial Owner              of Securities (1)   Percent (5)     Being Offered        of Securities    Percent (5)
 ----------------              -----------------   -----------     -------------        -------------    -----------
<S>                            <C>                              <C>                   <C>                <C>
William J. Young (2)           840,500 shares of                107,500 shares of     733,000 shares of
                               Common Stock            7.3%     Common Stock          Common Stock          6.4%

James Ewan (2)                 375,700 shares of                69,500 shares of      306,200 shares of
                               Common Stock            3.4%     Common Stock          Common Stock          2.8%

Alan R. Steel                  329,500 shares of                55,500 shares of      274,000 shares of
                               Common Stock            3.0%     Common Stock          Common Stock          2.5%

Vikram Dutt (2)                100,000 shares of
                               Common Stock               *     Same                  0                       0%

Robert M. Loeffler (2)         100,000 shares of
                               Common Stock               *     Same                  0                       0%

Haig S. Bagerdjian (2)         100,000 shares of
                               Common Stock               *     Same                  0                       0%

Dario Bianchi (4)              35,000 shares of                 30,000 shares of      5,000 shares of
                               Common Stock               *     Common Stock          Common Stock            0%

PeopleVision, Inc. (4)         15,000 shares of
                               Common Stock               *     Same                  0                       0%

Eugene G. Heller (3)           82,100 shares of                 75,000 shares of      7,100 shares of
                               Common Stock               *     Common Stock          Common Stock            0%
<FN>

*   Less than 1%.
(1) See table below for types of securities included.
(2) Messrs. Young, Ewan, Bagerdjian, Dutt and Loeffler are directors of the Company.
(3) Eugene G. Heller is a principal of Silverman Heller Associates, public relations counsel to the Company.
(4) Consultants to the Company.
(5) Percents are based on outstanding Common Stock as of June 30, 1998.
</FN>
</TABLE>

Ownership prior to registration in the above table consists of the following:

                                   Shares Owned
                            -------------------------
          Name              Unrestricted   Restricted    Options      Total
          ----              ------------   ----------    -------     -------
     William J. Young            233,000     107,500     500,000     840,500
     Dr. James Ewan                6,200      69,500     300,000     375,700
     Alan R. Steel                24,000      55,500     250,000     329,500
     Vikram Dutt                      --          --     100,000     100,000
     Robert M. Loeffler               --          --     100,000     100,000
     Haig S. Bagerdjian               --          --     100,000     100,000
     Dario Bianchi                 5,000          --      30,000      35,000
     PeopleVision, Inc.               --          --      15,000      15,000
     Eugene G. Heller              7,100          --      75,000      82,100


                              PLAN OF DISTRIBUTION

The shares of Common Stock  offered  hereby may be offered and sold from time to
time by the  Selling  Securityholders  listed  above,  or by  pledgees,  donees,
transferees or other successors in interest.  The Selling  Securityholders  will
act  independently  of the Company in making  decisions  with  respect to sales,
including, without limitation, the timing, manner and price of sales.

The shares of Common Stock covered by this Prospectus may be sold by the Selling
Securityholders  in one or more  transactions  on the Nasdaq  Stock  Market,  or
otherwise  at prices and at terms then  prevailing  or at prices  related to the
then current market price, or in negotiated  transactions.  In addition to other
manners of sale,  the  shares of Common  Stock may be sold in one or more of the
following  ways: (a) a block trade in which the broker or dealer so engaged will
attempt to sell the shares of Common  Stock as agent but may position and resell
a portion of the block as principal to facilitate the transaction; (b) purchases
by a broker or dealer as  principal  and resale by such broker or dealer for its
account pursuant to this prospectus; and (c) ordinary brokerage transactions and
transactions  in which the  broker  solicits  purchasers.  Thus,  the  period of
distribution of such shares of Common Stock may occur over an extended period of
time.

The Company will bear all costs and expenses of the  registration  of the Shares
under the Securities Act and certain state  securities  laws, other than fees of
counsel for the Selling Securityholders and any discounts or commissions payable
with respect to sales of such Shares.

In offering the securities,  the Selling  Securityholders and any broker-dealers
and any other  participating  broker-dealers  who execute  sales for the Selling
Securityholders  may be deemed to be  "underwriters"  within the  meaning of the
Securities Act in connection  with such sales,  and any profits  realized by the
Selling Securityholders and the compensation of such broker-dealer may be deemed
to be underwriting discounts and commissions. In addition, any shares covered by
this  Prospectus  which  qualify for sale pursuant to Rule 144 may be sold under
Rule 144 rather than pursuant to this Prospectus.

The Company has  advised  the Selling  Securityholders  that during such time as
they may be engaged in a  distribution  of securities  included  herein they are
required to comply with Rules 10b-6 and 10b-7 under the  Exchange  Act (as those
Rules are described in more detail below) and, in connection therewith that they
may not engage in any  stabilization  activity,  except as  permitted  under the
Exchange  Act, are required to furnish each  broker-dealer  through which Common
Stock included herein may be offered copies of this Prospectus,  and may not bid
for or purchase any securities of the Company or attempt to induce any person to
purchase any securities except as permitted under the Exchange Act.

Rule  10b-6  under  the  Exchange  Act  prohibits,   with  certain   exceptions,
participants in a distribution from bidding for or purchasing, for an account in
which the participant has a beneficial interest,  any of the securities that are
the subject of the  distribution.  Rule 10b-7 governs bids and purchases made in
order to stabilize the price of a security in connection  with a distribution of
the security.


                            DESCRIPTION OF SECURITIES

The  authorized  capital of AMV consists of 60,000,000  shares of Class A Common
Stock, no par value, 3,000,000 shares of Class B Common Stock, no par value, and
5,000,000  shares of preferred stock, no par value (the "Preferred  Stock").  At
June 30, 1998, there were 10,641,718 shares and 76,835 shares of the Class A and
Class B, respectively, and no shares of Preferred Stock outstanding.

Common Stock

General Provisions of Class A and Class B Common Stock

The Class A and Class B Common  Stock (the  "Common  Stock")  are  substantially
identical  on a  share-for-share  basis.  The holders of Common  Stock vote as a
single  class on all  matters  to come  before  stockholders  for a vote and may
cumulate their votes in the election of directors upon giving notice as required
by law. Each share of Class B Common Stock is  automatically  converted into one
share of Class A Common  Stock  upon its sale or  transfer,  or the death of the
holder.

All of the Common Stock is entitled to share  equally in dividends  from sources
available therefor when, as and if declared by the Board of Directors,  and upon
liquidation or  dissolution of AMV,  whether  voluntary or  involuntary,  and to
share equally in the assets of AMV available for  distribution to  stockholders.
Stockholders have no preemptive  rights.  All outstanding  shares are fully paid
(except for 200,000  shares of  restricted  Common  Stock),  non-assessable  and
legally issued.  The Board of Directors is authorized to issue additional shares
of Common  Stock  within the limits  authorized  by AMV's  charter  and  without
stockholder action.

Reference is made to AMV's Restated Articles of  Incorporation,  and Amended and
Restated  By-Laws,  as  well  as to the  applicable  statutes  of the  State  of
California,  for more  detailed  description  of the rights and  liabilities  of
stockholders.

Preferred Stock

Shares of Preferred Stock may be issued from time to time in one or more series;
and the AMV  Board  of  Directors,  without  further  stockholder  approval,  is
authorized  to fix the  dividend  rights and terms,  conversion  rights,  voting
rights  (whole,  limited or none),  redemption  rights  and  terms,  liquidation
preferences,  sinking funds and any other rights,  preferences,  privileges  and
restrictions  applicable to each such series of Preferred  Stock. The purpose of
authorizing  the AMV Board of Directors to determine such rights and preferences
is to eliminate delays associated with a stockholder vote on specific issuances.
The issuance of the Preferred Stock,  while providing  flexibility in connection
with possible  acquisitions  and other corporate  purposes,  could,  among other
things,  adversely  affect the voting  power of the holders of Common Stock and,
under certain  circumstances,  make it more  difficult for a third party to gain
control  of  the  Company;   such  issuance  also  could  adversely  affect  the
distributions  on and  liquidation  preferences  of the Class A Common  Stock by
creating  more  series of  Preferred  Stock  with  distribution  or  liquidation
preferences  senior to the Class A Common  Stock.  In the event  that  shares of
Preferred  Stock are issued as  securities  convertible  into  shares of Class A
Common Stock, the holders of Class A Common Stock may experience dilution.

In February 1998, the Company  implemented a stock rights  program.  Pursuant to
the program,  stockholders of record on February 27, 1998 received a dividend of
one right to purchase for $15 one  one-hundredth  of a share of a newly  created
Series A Junior Participating  Preferred Stock. The rights are attached to AMV's
Class A Common  Stock  and will also  become  attached  to shares  issued in the
future. The rights will not be traded separately and will not become exercisable
until the  occurrence of a triggering  event,  defined as an  accumulation  by a
single person or group of 20% or more of AMV's Class A Common Stock.  The rights
will expire on February 26, 2008 and are redeemable at $.0001 per right.

After a triggering  event, the rights will detach from the Class A Common Stock.
If AMV is then merged into, or is acquired by, another corporation,  the Company
has the  opportunity  to either (i) redeem the rights or (ii)  permit the rights
holder to  exercise  the  rights and to  receive  therefore  stock of AMV or the
acquiring  company  equal to two times the  exercise  price of the right  (i.e.,
$30).  Under  clause (ii) above,  the rights  attached to the  acquirer's  stock
become  null and void.  The effect of the rights  program is to make a potential
acquisition of the Company more expensive for the acquirer if, in the opinion of
AMV's Board of Directors, the offer is inadequate.

Schedule of Outstanding Stock, Warrants and Potential Dilution

In  addition  to the  Common  Stock  offered  hereby,  the  Company  has  issued
securities which, upon conversion or exercise,  will significantly  increase the
number  of shares  of Class A Common  Stock  outstanding.  The  following  table
summarizes, as of June 30, 1998, outstanding common stock, potential dilution to
the  outstanding  common  stock upon  exercise  of  warrants  or  conversion  of
convertible  debt, and proforma  proceeds or debt reduction from the exercise of
warrants  or  conversion  of debt.  The table  also sets forth the  exercise  or
conversion prices and warrant expiration and debt due dates.
<TABLE>
<CAPTION>
                                                                                                      Proforma
                                   Number or Principal                Common                          Proceeds
                                   Amount Outstanding               Stock After      Conversion        or Debt
          Security                  at June 30, 1998                Conversion          Price         Reduction
- ---------------------------------------------------------------------------------------------------------------
<S> <C>                               <C>                         <C>                  <C>          <C>        
Common Stock currently
    outstanding                         10,718,553                  10,718,553
                                      ------------                ------------
Warrants (expiration date):
    D (7/31/98)                            125,000                     125,000         $   2.75     $    344,000
    G (2/28/99)                            240,000                     240,000             2.00          480,000
    I (7/23/01)                            250,000 (A)                 250,000             2.25          563,000
    J (9/30/99)                            300,000                     300,000             2.03          609,000
                                                                  ------------                      ------------

                                                                       915,000                         1,996,000
                                                                  ------------                      ------------
Convertible Debt (due date):
    6.75% Notes (4/16/01)             $    900,000                     422,535             2.13          900,000
    6.75% Ventek Note (7/23/99)       $  2,250,000                   1,000,000             2.25        2,250,000
    Ventek Note (7/23/99)             $  1,529,000 (A)               1,800,000                         1,529,000
                                                                  ------------                      ------------

                                                                     3,222,535                         4,679,000
                                                                  ------------                      ------------
Potentially outstanding shares
    and proforma proceeds
    or reduction of debt                                            14,856,088                      $  6,675,000
                                                                  ============                      ============

<FN>
(A)  The Company  issued the  $1,529,000  note and Class I Warrant in connection
     with the Ventek  acquisition.  The note is  payable,  (a) at the  Company's
     option,  in cash or by delivery of up to 1,800,000 shares of Class A Common
     Stock on the third  anniversary  date of the note; or (b) solely in cash in
     the event AMV Common Stock is delisted from the Nasdaq Stock Market.
</FN>
</TABLE>

The proforma amounts above are for illustrative purposes only. Unless the market
price of AMV's Common Stock rises significantly above the exercise or conversion
prices, it is unlikely that any warrants will be exercised or that the debt will
be converted.

On June 30, 1998, AMV had outstanding  options to purchase  3,325,000  shares of
Common Stock  (including  options to purchase  420,000  shares of Common  Stock,
which Common Stock is being registered herein), 2,844,000 of which are under its
stock option plans.

Transfer and Warrant Agent

The  Transfer  and Warrant  Agent for AMV's Class A and Class B Common Stock and
Class D Warrants is American Stock Transfer & Trust Company, 40 Wall Street, New
York, NY 10005.

Reports to Stockholders

AMV intends to furnish to stockholders,  after the close of each fiscal year, an
annual  report  relating  to the  operations  of AMV  and  containing  financial
statements audited and reported upon by its independent public  accountants.  In
addition,  AMV  may  furnish  to  stockholders  such  other  reports  as  may be
authorized, from time to time, by the Board of Directors.

<PAGE>

================================================================================


No dealer, salesman or other person has
been authorized to give any information
or make any representations, other than
those contained in this Prospectus, in                   652,500 Shares of
connection with the offering hereby, and,               Class A Common Stock
if given or made, such information and
representations must not be relied upon
as having been authorized by the Company
or the Selling Securityholders.  This
Prospectus does not constitute an offer
to sell, or a solicitation of an offer
to buy, any securities to any person in
any State or other jurisdiction in which
such offer or solicitation is unlawful.                   ADVANCED MACHINE
Neither the delivery of this Prospectus                  VISION CORPORATION
nor any sale made hereunder shall, under
any circumstances, create any implication
that there has been no change in the
affairs of the Company or the facts
herein set forth since the date hereof.


         ---------------






                                                         ------------------

                                                             PROSPECTUS

                                                         ------------------











                                                            July 10, 1998







================================================================================
<PAGE>

                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.  Other Expenses of Issuance and Distribution

The following  table sets forth an itemized  statement of all the amounts of all
expenses to be incurred in connection with the issuance and  distribution of the
securities  that are the  subject of this  Registration  Statement.  The Company
shall bear such  expenses.  All amounts  shown,  other than the  Securities  and
Exchange Commission registration fee, are estimates.

Securities and Exchange Commission registration fee..............   $     390.75
Printing expenses................................................       2,000.00
Transfer Agent fees..............................................             --
Legal fees and expenses..........................................      10,000.00
Accounting fees and expenses.....................................       5,000.00
"Blue sky" fees and expenses.....................................       3,000.00
Miscellaneous expenses...........................................       4,609.25
                                                                    ------------

       Total.....................................................   $  25,000.00
                                                                    ============

Item 15.  Indemnification of Directors and Officers

Under  California  law, a  California  corporation  may  eliminate  or limit the
personal  liability of a director to the  corporation  for monetary  damages for
breach of the  director's  duty of care as a director,  provided that the breach
does not involve  certain  enumerated  actions,  including,  among other things,
intentional  misconduct  or knowing and culpable  violation of the law,  acts or
omissions  which the director  believes to be contrary to the best  interests of
the corporation or its shareholders or which reflect an absence of good faith on
the director's  part, the unlawful  purchase or redemption of stock,  payment of
unlawful  dividends  and receipt of improper  personal  benefits.  The Company's
Board of Directors  believes that such provisions have become  commonplace among
major  corporations  and are  beneficial in attracting  and retaining  qualified
directors, and the Company's Articles of Incorporation include such provisions.

The  Company's  Articles of  Incorporation  and By-Laws  also impose a mandatory
obligation  upon  Company to  indemnify  any  director or officer to the fullest
extent  authorized  or  permitted  by law (as  now or  hereinafter  in  effect),
including under circumstances in which indemnification would otherwise be at the
discretion of the Company.  In addition,  the Company has entered into indemnity
agreements  with each of its  directors  and officers  providing for the maximum
indemnification permitted or authorized by law.

The foregoing  indemnification  provisions are broad enough to encompass certain
liabilities of directors and officers under the Securities Act of 1933.

Item 16.  Exhibits

The following exhibits,  which are furnished with this Registration Statement or
incorporated by reference, are filed as part of this Registration Statement:

Exhibit
Number   Description
- -------  -----------

3.1      Restated Articles of Incorporation of the Company as amended to date. *

4.4      Form of Class D Warrant Agreement. *

4.6      Form of Class G Warrant Agreement. *

4.7      Form of Class I Warrant Agreement. *

4.8      Form of Class J Warrant Agreement. *

4.9      Form of stock option agreement. *

4.10     Form of 1997 Restricted Stock Plan and restricted stock agreement. *

4.11     Rights Agreement dated February 27, 1998 between the Company and
         American Stock Transfer and Trust Company. *

5.1      Opinion of Troy & Gould Professional Corporation regarding the legality
         of the securities registered hereunder. *

23.1     Consent of PricewaterhouseCoopers LLP (contained in Part II).

23.2     Consent of Troy & Gould Professional Corporation (contained in Exhibit
         5.1).

- -------------------
* Previously filed.


Item 17.  Undertakings

       (a)   The undersigned Company hereby undertakes:

             (1) To file,  during any period in which  offers or sales are being
made of the securities  registered  hereby, a  post-effective  amendment to this
registration statement.

                 (i)  To  include any prospectus required by section 10(a)(3) of
the Securities Act;

                 (ii)  To reflect in the  prospectus any facts or events arising
after the  effective  date of this  registration  statement  (or the most recent
post-effective  amendment  thereof)  which,  individually  or in the  aggregate,
represent a fundamental change in the information set forth in this registration
statement;

                 (iii)  To include any material  information with respect to the
plan of distribution not previously  disclosed in the registration  statement or
any material change to such information in the registration statement; provided,
however, that (i) and (ii) do not apply if the registration statement is on Form
S-3, and the information  required to be included in a post-effective  amendment
is contained in periodic reports filed by the registrant  pursuant to section 13
or section 15(d) of the Exchange Act that are  incorporated  by reference in the
registration statement.

             (2) That,  for the purpose of determining  any liability  under the
Securities Act, each such  post-effective  amendment shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

             (3) To  remove  from  registration  by  means  of a  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.

       (b)   The undersigned Company hereby undertakes:

That for purposes of determining  any liability  under the Securities  Act, each
filing of the  registrant's  annual report  pursuant to section 13(a) or section
15(d) of the Exchange  Act (and,  where  applicable,  each filing of an employee
benefit plan's annual report pursuant to section 15(d) of the Exchange Act) that
is incorporated by reference in the registration statement shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

       (c)  Insofar  as  indemnification   for  liabilities  arising  under  the
Securities Act may be permitted to directors,  officers and controlling  persons
of the Company pursuant to the foregoing provisions,  or otherwise,  the Company
has been advised that in the opinion of the Commission such  indemnification  is
against  public  policy as expressed in the  Securities  Act and is,  therefore,
unenforceable.  In the  event  that a claim  for  indemnification  against  such
liabilities  (other than the payment by the Company of expenses incurred or paid
by a director,  officer or  controlling  person of the Company in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling  person in connection with the securities being  registered,  the
Company  will,  unless in the opinion of its counsel the matter has been settled
by  controlling  precedent,  submit to a court of appropriate  jurisdiction  the
question  whether  such  indemnification  by  it is  against  public  policy  as
expressed in the Securities  Act and will be governed by the final  adjudication
of such issue.

<PAGE>

                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  registrant
certifies  that it has  reasonable  grounds  to  believe  that it meets  all the
requirements  for filing on Form S-3 and has duly caused this Amendment No. 1 to
this  registration  statement  to be  signed on its  behalf by the  undersigned,
thereunto duly authorized in the city of Medford, Oregon on July 10, 1998.


                                     ADVANCED MACHINE VISION CORPORATION


                                     By:  /s/ Alan R. Steel
                                     -------------------------------------------
                                          Alan R. Steel
                                          Vice President, Finance and
                                          Chief Financial Officer


                                POWER OF ATTORNEY

Pursuant to the requirements of the Securities Act of 1933, this Amendment No. 1
to this  registration  statement  has been  signed by the  following  persons on
behalf of the registrant and in the capacities and on the dates indicated.
<TABLE>
<CAPTION>

         Signature                               Title                            Date
- -------------------------------     -------------------------------------    -------------
<S>                                 <C>                                      <C>
*                                   Chairman of the Board of Directors,
- -------------------------------     Chief Executive Officer and President
William J. Young                    Principal Executive Officer              July 10, 1998


/s/ Alan R. Steel                   Chief Financial Officer
- -------------------------------     Principal Financial and                  July 10, 1998
Alan R. Steel                       Accounting Officer

*                                   Director                                 July 10, 1998
- ------------------------------
Haig S. Bagerdjian

*                                   Director                                 July 10, 1998
- ------------------------------
Vikram Dutt

*                                   Director                                 July 10, 1998
- ------------------------------
James Ewan

*                                   Director                                 July 10, 1998
- ------------------------------
Robert M. Loeffler

*                                   Director                                 July 10, 1998
- ------------------------------
Jack Nelson

*                                   Director                                 July 10, 1998
- ------------------------------
Rodger A. Van Voorhis


* by /s/ Alan R. Steel              Attorney-in-Fact                         July 10, 1998
- ------------------------------
Alan R. Steel

</TABLE>
<PAGE>

                                  EXHIBIT INDEX

Exhibit                                                          Sequential
Number                 Description                               Page Number
- -------   -----------------------------------------              -----------

3.1       Restated Articles of Incorporation of the
          Company as amended to date. (6)

4.4       Form of Class D Warrant Agreement. (1)

4.6       Form of Class G Warrant Agreement. (2)

4.7       Form of Class I Warrant Agreement. (4)

4.8       Form of Class J Warrant Agreement. (7)

4.9       Form of stock option agreement. (1)

4.10      Form of 1997 Restricted Stock Plan and
          restricted stock agreement. (4)

4.11      Rights Agreement dated February 27, 1998
          between the Company and American Stock
          Transfer and Trust Company. (6)

5.1       Opinion of Troy & Gould Professional
          Corporation regarding the legality of
          the securities registered hereunder. (7)

23.1      Consent of PricewaterhouseCoopers LLP
          (contained in Part II).                                     20

23.2      Consent of Troy & Gould Professional
          Corporation (contained in Exhibit 5.1). (7)

- ----------------------


(1)       Previously filed as an exhibit to Form S-1 (File No. 33-45126).

(2)       Filed with the SEC on April 14, 1996,  as an exhibit to the  Company's
          Form 10-K for the year ended December 31, 1995.

(3)       Filed with the SEC on July 30,  1996,  as an exhibit to the  Company's
          Form 8-K dated July 24, 1996.

(4)       Filed with the SEC on January 22, 1997, as an exhibit to the Company's
          Form 8-K dated January 9, 1997.

(5)       Filed with the SEC on May 14, 1997 as an exhibit to the Company's Form
          10-Q for the quarter ended March 31, 1997.

(6)       Filed with the SEC on February 20, 1998 as an exhibit to the Company's
          Form 8-A.

(7)       Filed with the SEC on May 28, 1998 as an exhibit to the Company's Form
          S-3 dated May 28, 1998.

<PAGE>



                                  EXHIBIT 23.1

                       Consent of Independent Accountants


We  hereby  consent  to  the   incorporation  by  reference  in  the  Prospectus
constituting part of this Registration Statement on Form S-3 of our report dated
January 23, 1998, except as to the subsequent warrant  expirations  described in
Note 10,  which is as of  March  10,  1998,  appearing  on page F-2 of  Advanced
Machine  Vision  Corporation's  Annual  Report on Form 10-K/A for the year ended
December 31, 1997.




/s/ PricewaterhouseCoopers LLP
- ------------------------------
PricewaterhouseCoopers LLP

Portland, Oregon
July 10, 1998



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission